ReviewFrontiers in nutrition2026
Nutrition phenotypes in inflammatory bowel disease: emerging concepts and future directions to guide clinical practice.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nutrition occupies a central and dynamic role across the inflammatory bowel disease (IBD) care continuum, from disease risk reduction and prevention, through induction and maintenance of remission, to the mitigation of disease-related and unrelated complications and the preservation of quality of life - yet translating this evidence into individualized clinical practice remains a persistent challenge. To address this gap, we conducted a narrative review of the current literature and propose the concept of the nutrition phenotype: a structured framework that integrates disease-specific characteristics, nutritional status, body composition, dietary patterns, and lifestyle factors to define clinically distinct patient profiles. Applying this framework to six phenotypes: malnutrition, overnutrition, dietary therapeutics, functional symptoms, high enteric loss, and complication prevention, we synthesize the evidence supporting targeted nutritional interventions for each and present an integrated clinical algorithm plus a proposed hierarchy for managing patients with overlapping phenotypes to guide prioritization and decision-making. This phenotype-driven approach provides a practical, personalized structure for nutrition care in inflammatory bowel disease, with the aim of improving implementation feasibility and patient outcomes across real-world clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.